Cannabis wins, bye bye Chevron and RIP Schedule 1 The new Cheveron ruling will be a major help in our Massachsetts Boise cannabis case lawsuit seeking to bar the government from enforcing federal drug laws against state regulated cannabis companies. https://www.reuters.com/legal/government/cannabis-companies-massachusetts-challenge-constitutionality-federal-drug-law-2023-10-26/
"As you can see, DEA’s reasons for keeping cannabis in schedule I are indefensible. The only reason they survived judicial review is that they were blessed by the D.C. Circuit during the reign of a sytle of reflexive Chevron deference that courts have long since abandoned."
https://ondrugs.substack.com/p/president-bidens-scheduling-directive-19b
"Case Western law professor Jonathan Adler, generally agreed with Friday's ruling, though he added that it may make it harder for the executive branch to react to major crises, like the COVID pandemic, or sudden disasters in the financial world: “This decision will make it more difficult for future administrations to change policy without going to Congress,” he said, noting that if there is a second Trump administration, “they will find out what it’s like to get what they wished for because, in a lot of contexts, it will be hard to dramatically change the way various federal statutes are implemented.” VERY Good News for cannabis https://www.npr.org/2024/06/10/nx-s1-4998861/supreme-court-chevron-doctrine